Recital 14, Regulation (EU) 2024/3169

In forcesince 18 Dec 2024

With the view of facilitating the discussion with the health technology developer and consultation of individual experts at the meeting referred to in Article 18(7) of Regulation (EU) 2021/2282, the JSC Subgroup, via the HTA secretariat, should share with the health technology developer the list of issues indicating the topics to be addressed at the meeting and where relevant the specific questions to be addressed only in writing before that meeting (‘the list of issues’). The JSC Subgroup should give the health technology developer the opportunity to respond to the list of issues in writing in due time before the meeting.